---
figid: PMC7289676__nihms-1591731-f0001
figtitle: 'ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The
  Pediatric Perspective'
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Coronaviridae
- Severe acute respiratory syndrome-related coronavirus
- Respiratory syncytial virus
- Homo sapiens
- Mus musculus
pmcid: PMC7289676
filename: nihms-1591731-f0001.jpg
figlink: /pmc/articles/PMC7289676/figure/F1/
number: F1
caption: 'Balance of the RAAS and Impact of Age, Disease, SARS-CoV-2, and ACE inhibitors
  and ARBsA: In younger and healthier individuals (e.g. children), the RAAS is in
  balance: blood pressure is appropriate and no disease develops.B: With advancing
  age and in various disease states (e.g. hypertension), there is a shift towards
  the ACE/Ang II pathway.C: ACEi and ARB block the ACE/Ang II pathway and shift the
  RAAS towards ACE2/Ang-(1–7).D: SARS-CoV-2-induced ACE2 downregulation could stimulate
  a shift towards the ACE/Ang II pathway to propagate acute lung injury in COVID-19.E:
  In patients with COVID-19, ACEi and ARB therapy could block the ACE/Ang II pathway
  and shift the RAAS towards the ACE2/Ang-(1–7) pathway to mitigate lung injury.Pro-inflammatory
  and pro-fibrotic pathway in red, anti-inflammatory and anti-fibrotic pathway in
  blue. Dashed lines indicate decreased pathway activity. ACE, angiotensin-converting
  enzyme; ACEi, ACE inhibitors; Ang, angiotensin; ARB, angiotensin II receptor blocker;
  AT1R, Ang II type 1 receptor; COVID-19, coronavirus disease 2019; MasR, Mas receptor;
  RAAS, renin-angiotensin-aldosterone system; SARS-CoV-2, severe acute respiratory
  syndrome coronavirus 2.'
papertitle: 'ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The
  Pediatric Perspective.'
reftext: Andrew M. South, et al. Hypertension. ;76(1):16-22.
year: '2020'
doi: 10.1161/HYPERTENSIONAHA.120.15291
journal_title: 'Hypertension (Dallas, Tex. : 1979)'
journal_nlm_ta: Hypertension
publisher_name: ''
keywords: Angiotensin-(1–7) | cardiovascular disease | children | chronic kidney disease
  | coronavirus | hypertension | renin-angiotensin-aldosterone system | SARS-CoV-2
automl_pathway: 0.9334862
figid_alias: PMC7289676__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7289676__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7289676__nihms-1591731-f0001.html
  '@type': Dataset
  description: 'Balance of the RAAS and Impact of Age, Disease, SARS-CoV-2, and ACE
    inhibitors and ARBsA: In younger and healthier individuals (e.g. children), the
    RAAS is in balance: blood pressure is appropriate and no disease develops.B: With
    advancing age and in various disease states (e.g. hypertension), there is a shift
    towards the ACE/Ang II pathway.C: ACEi and ARB block the ACE/Ang II pathway and
    shift the RAAS towards ACE2/Ang-(1–7).D: SARS-CoV-2-induced ACE2 downregulation
    could stimulate a shift towards the ACE/Ang II pathway to propagate acute lung
    injury in COVID-19.E: In patients with COVID-19, ACEi and ARB therapy could block
    the ACE/Ang II pathway and shift the RAAS towards the ACE2/Ang-(1–7) pathway to
    mitigate lung injury.Pro-inflammatory and pro-fibrotic pathway in red, anti-inflammatory
    and anti-fibrotic pathway in blue. Dashed lines indicate decreased pathway activity.
    ACE, angiotensin-converting enzyme; ACEi, ACE inhibitors; Ang, angiotensin; ARB,
    angiotensin II receptor blocker; AT1R, Ang II type 1 receptor; COVID-19, coronavirus
    disease 2019; MasR, Mas receptor; RAAS, renin-angiotensin-aldosterone system;
    SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Agt
  - Atr
  - Mmab
  - Ace
  - Agtr1a
  - Ace2
  - Sars1
  - Mas1
  - BEST1
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - ANGPT2
  - VPS51
  - ACE
  - AGTR1
  - ATM
  - SLC33A1
  - PGR-AS1
  - ACE2
  - SARS1
  - SARS2
---
